Nisa Investment Advisors’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $29.5K | Buy |
4,281
+266
| +7% | +$1.83K | ﹤0.01% | 1759 |
|
2025
Q1 | $11.6K | Buy |
4,015
+2,348
| +141% | +$6.76K | ﹤0.01% | 2062 |
|
2024
Q4 | $7.84K | Buy |
1,667
+328
| +24% | +$1.54K | ﹤0.01% | 2187 |
|
2024
Q3 | $4.78K | Sell |
1,339
-203
| -13% | -$725 | ﹤0.01% | 2233 |
|
2024
Q2 | $9.56K | Hold |
1,542
| – | – | ﹤0.01% | 2167 |
|
2024
Q1 | $14.6K | Hold |
1,542
| – | – | ﹤0.01% | 1968 |
|
2023
Q4 | $10.4K | Hold |
1,542
| – | – | ﹤0.01% | 2036 |
|
2023
Q3 | $6.85K | Hold |
1,542
| – | – | ﹤0.01% | 2241 |
|
2023
Q2 | $5.09K | Buy |
1,542
+42
| +3% | +$139 | ﹤0.01% | 2323 |
|
2023
Q1 | $4K | Sell |
1,500
-152
| -9% | -$405 | ﹤0.01% | 2261 |
|
2022
Q4 | $12K | Buy |
1,652
+509
| +45% | +$3.7K | ﹤0.01% | 2166 |
|
2022
Q3 | $9K | Buy |
1,143
+920
| +413% | +$7.24K | ﹤0.01% | 2210 |
|
2022
Q2 | $1K | Sell |
223
-16,977
| -99% | -$76.1K | ﹤0.01% | 2359 |
|
2022
Q1 | $407K | Buy |
17,200
+14,840
| +629% | +$351K | ﹤0.01% | 1142 |
|
2021
Q4 | $29K | Sell |
2,360
-3,590
| -60% | -$44.1K | ﹤0.01% | 1856 |
|
2021
Q3 | $168 | Buy |
5,950
+900
| +18% | +$25 | ﹤0.01% | 1475 |
|
2021
Q2 | $53 | Buy |
+5,050
| New | +$53 | ﹤0.01% | 1923 |
|